| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |